LAXMI SANKALPA BHAGANAGARAPU; SARUMATHY SUNDARARAJAN. NOVEL APPROACHES FOR ANEMIA IN CARDIORENAL SYNDROME: A RANDOMIZED CONTROLLED TRIAL OF HYPOXIA-INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITOR VS SGLT2 INHIBITOR. Asian Journal of Pharmaceutical and Clinical Research, [S. l.], v. 18, n. 12, p. 184–191, 2025. DOI: 10.22159/ajpcr.2025v18i12.57009. Disponível em: https://www.journals.innovareacademics.in/index.php/ajpcr/article/view/57009. Acesso em: 14 dec. 2025.